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Adjusted Blood Requirement Index as Indicator of Failure to Control Acute 
Variceal Bleeding
Aim To estimate the clinical value of adjusted blood requirement index 
(ABRI) in relation to other criteria for failure of variceal bleeding control 
proposed at Baveno consensus workshops and to evaluate ABRI as an early 
predictor of occurrence of other Baveno criteria and identification of pos-
sible predictors of unfavorable ABRI.
Methods We retrospectively analyzed the data on 60 patients admitted to 
the hospital due to acute variceal bleeding. Number of treatment failures 
according to Baveno II-III and Baveno IV definitions and criteria was com-
pared. We tested the ABRI’s predictability of other Baveno IV and Baveno 
II-III criteria. Logistic regression analysis was performed to ascertain inde-
pendent variables that predict ABRI≥0.75.
Results Failure to control variceal bleeding occurred in 40 of 60 patients 
according to Baveno II-III criteria, and in 35 of 60 patients according to 
Baveno IV criteria. Excluding the criterion of “transfusion of 2 units of 
blood or more (over and above the previous transfusions)”and ABRI cri-
terion, failure to control variceal bleeding was observed in 17 and 14 of 60 
patients, respectively. Congruence of ABRI with other criteria was present 
in about two-thirds of the cases. ABRI≥0.75 was associated with increased 
risk of positive other Baveno criteria, particularly modified Baveno II-III 
(odds ratio [OR] 4.10; 95% confidence interval [CI], 1.11-15.05) and 
Baveno IV without ABRI (OR 4.37; 95% CI, 1.04-18.28). Independent 
predictors of ABRI≥0.75 identified in logistic regression analysis were male 
sex (P<0.001) and higher hematocrit values (P=0.004).
Conclusion We found low congruence between ABRI and other Baveno 
criteria and the incidence of treatment failure in our study was higher than 
the previously reported frequencies of early rebleeding. It seems that crite-
ria related to the quantity of blood transfusions are not reliable indicators 
of treatment failure.
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Prevalence of esophageal varices in patients with 
liver cirrhosis is high, as by the time of diagnosis, 
they are present in up to 40% of compensated pa-
tients and up to 60% of those who present with 
ascites (1-3). Approximately 30% of patients ex-
perience an episode of variceal hemorrhage with-
in 2 years of the diagnosis of varices (4,5). Acute 
bleeding from varices in a patient with portal hy-
pertension often poses a life-threatening medi-
cal emergency with a mortality that is, in spite of 
the recent progress, still around 20% at 6 weeks 
(6,7). Bleeding-associated mortality is highest in 
the first 5 days after the first episode of variceal 
bleeding and returns to baseline after 3-4 months 
(5,8).
Several definitions and criteria to evaluate 
failure to control variceal bleeding and failure to 
prevent variceal rebleeding, as well as prognos-
tic indicators of rebleeding, were developed pre-
viously at three Baveno Consensus Workshops 
(9-13). With application in clinical trials, it has 
been found that they have a limited clinical value 
(14). Therefore, new definitions and criteria have 
been recently proposed at Baveno IV Consensus 
Workshop (14). Adjusted blood requirement in-
dex (ABRI) has been suggested as an independent 
criterion to define the failure to control bleeding, 
but it has not been validated yet.
The aims of this study were to evaluate the 
clinical significance and consistency of ABRI in 
relation to other criteria of failure to control var-
iceal bleeding proposed at Baveno Consensus 
Workshops (9-14), to determine if ABRI could 
be used as an early predictor of occurrence of 




We retrospectively analyzed medical records of a 
total of 87 patients with acute variceal bleeding 
admitted to the Interventional Gastroenterology 
Unit of the Sisters of Mercy University Hospital 
between March 1, 2002, and December 31, 2005. 
All patients who received blood transfusion(s) 
and survived at least to the end of the first trans-
fusion were eligible for the study. Eighteen pa-
tients who did not need a transfusion, 2 patients 
who died before the start of transfusion, and 7 
patients who died in the course of the first trans-
fusion were excluded from the study. Baseline 
data on demographic and clinical characteristics 
were collected for the remaining 60 patients (Ta-
ble 1). Median age of the patients was 56.5 years, 
ranging from 32 to 83 years. Forty-five patients 
were men.
Patient data were entered in a Microsoft Ac-
cess database (Microsoft Corporation, Redmond, 
WA, USA). Occurrence of each of Baveno II/III 
and Baveno IV criteria for the treatment failure 
was entered separately. For the purpose of data 
analysis, modified Baveno criteria II-III were de-
fined as Baveno criteria II-III without the “trans-
fusion of 2 or more blood units (above the pre-
vious transfusions)” criterion. ABRI values were 
calculated according to the following formula for 
each transfusion received: ABRI = blood units 
transfused/[(final hematocrit–initial hemato-
Table 1. Demographic and clinical characteristics of 60 patients 
with acute variceal bleeding
Parameter No. of patients (n = 60)








 gastroesophageal junction  3
 cardia 17
Varices grade (16)�







 band ligation  4
Treated with octreotide 25
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crit)+0.01] According to Baveno IV criteria, 
ABRI≥0.75 at any time point defines failure to 
control bleeding.
Statistical analysis
Continuous variables were presented as medians 
and interquartile ranges, and categorical variables 
as frequencies. Nonparametric Mann-Whit-
ney’s test was used to test the significance of dif-
ference between quantitative variables. For cate-
gorical variables, Fisher exact test was used. Logit 
analysis was performed to test if ABRI predicted 
occurrence of other clinical manifestations pro-
posed as the criteria for failure to control bleed-
ing; the results were presented as odds ratios 
(OR) with 95% confidence interval (95% CI). 
Patients with ABRI≥0.75 and those with ABRI 
<0.75 were compared by all relevant demograph-
ic, clinical, and laboratory variables. Logistic re-
gression analysis was performed to ascertain in-
dependent variables that predicted ABRI≥ 0.75. 
Criteria for inclusion of variables in the logis-
tic regression models were based on evidence 
of an association (P<0.1) in the bivariate analy-
sis. The appropriateness of the fitted model and 
its predictive utility were confirmed. Summary 
measures of goodness of fit were evaluated us-
ing Hosmer-Lemeshow test. Interactions were 
assessed by running correlation matrix or logit 
analysis. P<0.05 was considered statistically sig-
nificant. All statistical analyses were performed 
with SAS software 8.0 (SAS Institute Inc., Cary, 
NC, USA).
Results
There were three times more men than women 
with acute variceal bleeding (Table 1). Esopha-
gus was the most common localization of bleed-
ing varices (Table 1). In 45 of 60 patients, hem-
orrhage resulted from varices grade II/III or III. 
According to Child-Turcotte-Pugh classifica-
tion, most patients were class B (15). N-butyl-cy-
anoacrylate was the most frequently used endo-
scopic treatment modality, applied in more than 
half of the patients, whereas octreotide was ad-
ministered in 25 patients.
ABRI vs Baveno criteria
According to Baveno II-III criteria, failure to 
control acute variceal bleeding occurred in 40 
patients (Table 2). The “transfusion of 2 units 
of blood or more (over and above the previ-
ous transfusions)” criterion was present in 36 of 
these patients, while all other Baveno II-III cri-
teria combined were present in only 17 patients. 
Table 2. Treatment failure of acute variceal bleeding according to different criteria
Treatment failure criteria No. of patients (n = 60)
Baveno II-III (12)�� 40
transfusion of 4 units of blood or more within the first 6 h  1
inability to achieve an increase in systolic blood pressure of 20 mm Hg or to 70 mm Hg or more within the first 6 h  0
inability to achieve a pulse reduction of 20/min from baseline or to <100/min within the first 6 h  0
occurrence of hematemesis  7
reduction in blood pressure of more than 20 mm Hg from the 6-h point 13
increase in pulse rate of more than 20/min from the 6-h point on 2 consecutive readings 1 h apart  3
transfusion of 2 units of blood or more (over and above the previous transfusions) required to increase the hematocrit 
  to above 27% or hemoglobin to above 90 g/L
36
Baveno IV (14)��† 35
fresh hematemesis ≥2 h after the start of treatment  7
30-g drop in hemoglobin ( ≈ 9% drop in hematocrit) if no transfusion is administered  8
death  2
adjusted blood requirement index (ABRI)≥0.75 at any time point 32
Modified Baveno II-III‡ 17
Baveno IV without ABRI‡ 14
Overall incidence of treatment failure 46
Endoscopic reintervention  6
�Occurrence of any single criterion signifies failure to control variceal bleeding.
†The time frame for the acute bleeding episode is 120 h.
‡Baveno II-III criteria excluding “transfusion of 2 units of blood or more (over and above the previous transfusions)” criterion and Baveno IV criteria without ABRI criterion, as defined 
by authors.
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According to Baveno IV criteria, failure to con-
trol acute variceal bleeding occurred in 35 pa-
tients (Table 2). ABRI≥0.75 as the only criterion 
occurred in 21 of these patients. 
Congruence between ABRI and other Bave-
no criteria was present in over half of the pa-
tients, with ABRI sensitivity ranging between 
62.5% and 78.6% and ABRI specificity between 
54.4% and 65.0% (Table 3). Baveno II-III crite-
ria excluding the “transfusion of 2 units of blood 
or more (over and above the previous transfu-
sions)” criterion were congruent with Baveno IV 
criteria excluding ABRI criterion in 49 patients 
(Table 3).
Predictive value of ABRI
Logit analysis showed that ABRI≥0.75 was as-
sociated with increased risk of other Baveno cri-
teria, particularly modified Baveno II-III criteria 
and Baveno IV criteria excluding ABRI criterion 
(Table 4) In a group of 25 patients where ABRI 
and other criteria were both present, ABRI had 
occurred before other criteria in 8 patients.
Predictors of unfavorable ABRI
Bivariate analysis to test predictors of ABRI≥0.75 
included age, sex, varices localization and grade, 
Child B and Child C classes, prothrombin time 
expressed as international normalized ratio 
(INR), first hemoglobin and hematocrit value, 
and treatment modalities (Table 5). Only 2 of 
these variables, male sex and higher hematocrit 
values, were identified as predictors of poor out-
come based on the evaluation of ABRI. Logistic 
regression analysis using ABRI≥0.75 as the out-
come variable identified male sex (OR, 14.0; 95% 
CI, 2.9-111.9, P = 0.003) and higher hematocrit 
values as independent predictors. Increase in he-
matocrit by 1% increased the risk of unfavorable 
ABRI by 10% (OR per unit change, 1.10; 95% 
Table 3. Relation of adjusted blood requirement index (ABRI) and other Baveno criteria in 60 patients with acute variceal bleeding
ABRI (No. of patients)
Criteria� <0.75 (n = 28) ≥0�7�� �n. 5 (  = 32) P congruity sensitivity (%) specificity �%)
Baveno II-III (12)�
 positive 15 25 0.057 38 62.5 65.0
 negative 13  7
Modified Baveno II-III:
 positive  4 13 0.043 37 76.5 55.8
 negative 24 19
Baveno IV without ABRI�
 positive  3 11 0.037 36 78.6 54.4
 negative 25 21
�Modified Baveno II-III criteria excluding “transfusion of 2 or more blood units (above the previous transfusions)” criterion, and Baveno IV criteria without ABRI criterion, as defined by 
authors.
Table 4. Logit analysis of the dependence of Baveno criteria on 
adjusted blood requirement index (ABRI)
Criteria� Odds ratio �9��% confidence interval) P
Baveno II-III (12) 3.10 (0.99-9.71) 0.052
Modified Baveno II-III 4.10 (1.11-15.05) 0.034
Baveno IV without ABRI 4.37 (1.04-18.28) 0.044
�Modified Baveno II-III criteria excluding “transfusion of 2 or more blood units (above 
the previous transfusions)” criterion, and Baveno IV criteria without ABRI criterion, as 
defined by authors.
Table 5. Bivariate analysis of independent predictors of adjusted 
blood requirement index ≥0.75�
ABRI (No. of patients)
Variable ≥7�� �n5 (  = 32) <75 (n = 28) P
Age (median, IQ range, years) 55 (47.5-71.0) 57 (52.0-65.8) 0.138
Men/women 30/2 15/13 0.001
Source of bleeding�
 esophagus 21 19 0.892
 gastroesophageal junction  2  1
 cardia  9  8
Varices grade (16)�
 I and II  9  6 0.761
 II/III and III 23 22
Child-Turcotte-Pugh class (15)�
 A  7  6 0.613
 B 15 10
 C 10 12
Pretreatment hemoglobin 
 (median, IQ range; g/L)
83 (64.5-99.8) 73 (54.3-84.0) 0.014
Hematocrit (median, IQ range) 25 (18.8-30.0) 21.5 (16.3-24.8) 0.004
Prothrombin time 
 (median, IQ range; INR)
1.47 (1.3-1.7) 1.5 (1.4-1.8) 0.157
Histoacryl treatment 19 17 1
Polidocanol treatment 12  5 0.152
Band ligature  1  3 NE
Octreotide 11 14 0.296
�Abbreviations� ABRI – adjusted blood requirement index; IQ – interquartile range; INR 
– international normalized ratio� NE – not evaluated.
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CI, 1.01-1.28; P = 0.004). Treatment modalities 
did not show any influence on ABRI (Table 5).
Discussion
We showed that ABRI has a limited value as an 
independent predictor of failure to control acute 
variceal bleeding. In comparison with previously 
reported early rebleeding rates of 13% (6,7), we 
observed unusually high proportion of patients 
in whom control of variceal bleeding failed ac-
cording to complete Baveno II-III and Bave-
no IV criteria (66.7% and 58.3%, respectively). 
Therefore, we separately analyzed the occurrence 
of treatment failure according to our modifica-
tion of Baveno II-III criteria, where we excluded 
the “transfusion of 2 units of blood or more (over 
and above the previous transfusions)”criterion, 
and Baveno IV criteria without ABRI. Accord-
ing to these criteria, 28.3% and 23.3% of patients 
had treatment failure, respectively. These per-
centages are closer to the rates reported previous-
ly (6,7). The proportion of patients who actual-
ly underwent endoscopic retreatment was even 
lower. These results indicated that criteria relat-
ed to the quantity of blood transfusions, ie, both 
ABRI and “transfusion of 2 units of blood or 
more (over and above the previous transfusions)” 
criterion, were not reliable indicators of treat-
ment failure. The congruence of ABRI with oth-
er criteria of treatment failure was low, although 
we confirmed the possible role of ABRI as a pre-
dictor of occurrence of other, clinical criteria in-
cluded in Baveno IV and Baveno II-III criteria.
When we used ABRI as a dependent out-
come variable, we were not able to identify reli-
able independent predictors of ABRI≥0.75, al-
though we found that male sex and higher initial 
hematocrit value were the factors independently 
associated with high ABRI. The clinical meaning 
of that finding is elusive.
Our study has several limitations. It is a ret-
rospective, single-center study with a relatively 
small number of patients. Therefore, the power 
of the study is decreased. Due to its retrospective 
character, the difference in timing of blood draw-
ing cannot be excluded as a possible factor that 
influenced ABRI. Other factors that could also 
significantly influence ABRI, such as transfusion-
related complications and extravascular hemor-
rhage (hematoma), were not observed. However, 
this study is the first one performed to evaluate 
ABRI in patients with acute variceal bleeding. A 
multicenter, prospective study with larger num-
ber of patients is needed for further validation of 
ABRI as an independent indicator of treatment 
failure in patients with acute variceal bleeding.
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